A tumor marker, CA125, is known to increase in the serum or other body fluids in various malignancies such as ovarian cancer. Here we present a case of progressive systemic sclerosis (PSS) with massive pleural effusion, in which CA125 in the serum and pleural fluid were elevated. The serum level of CA125 decreased in accordance with the change of the pleural effusion. CA125 level may be an indicator for the activity of serositis in some cases with collagen vascular diseases.
Good JT Jr , King TE , Antony VB , Sahn SA . Lupus pleuritis. Clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies . Chest1983; 84: 714–718 .
5.
Tomita Y . Clinical evaluation and tissue distribution of CA125 in patients with pleural effusion . Igaku Kenkyu1989; 59: 90–96 .
6.
Bateman AC , al-Talib RK , Newman T et al. Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression . Histopathology1997; 30: 49–56 .
7.
Ho-dac-Pannekeet mm , Hiralall JK , Struijk DG , Krediet RT . Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis . Adv Perit Dial1997; 13: 17–22 .
8.
Lai KN , Lai KB , Szeto CC et al. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters . Am J Kidney Dis1997; 29: 699–705 .
9.
Owens MW , Grimes SR . Pleural cell response to inflammation: tumor necrosis factor-induced mitogenesis and collagen synthesis . Am J Physiol1993; 265 (4 Pt 1): L382–L388 .
10.
Kimura K , Ezoe K , Yokozki H et al. Elevated serum CA125 in progressive systemic sclerosis with pleural effusion . J Dermatol1995; 22: 28–31 .
